{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:58:02Z","timestamp":1760057882311,"version":"build-2065373602"},"reference-count":46,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dermatology, Pediatric Dermatology, and Oncology Clinic, Medical University of Lodz, Poland","award":["503\/1-064-01\/503-11-001"],"award-info":[{"award-number":["503\/1-064-01\/503-11-001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objective: Psoriasis is a chronic inflammatory skin disease. Studies on adult population have confirmed that there is an association between psoriasis and metabolic as well as cardiovascular diseases. The aim of this study was to evaluate the inflammatory potential and the association of psoriasis with metabolic and cardiovascular risk by analyzing serum concentrations of homocysteine, adiponectin, resistin, leptin, and pentraxin 3 in pediatric patients with psoriasis. Additionally, the study explored correlations between these biomarkers and psoriasis severity. Methods: The study included 75 pediatric patients (47 girls and 28 boys) aged 2\u201317 years with clinically confirmed psoriasis. In addition, 28 healthy children (15 girls and 13 boys) without psoriasis, metabolic or inflammatory diseases made up the control group. Psoriasis severity was evaluated using the scales psoriasis area and severity index (PASI) and the body surface area (BSA). Serum concentrations of homocysteine, adiponectin, pentraxin 3, resistin, and leptin were measured in both groups. Results: Children with psoriasis exhibited higher serum levels of homocysteine, resistin, leptin, and pentraxin 3 and lower serum levels of adiponectin compared to the control group. A positive correlation was observed between resistin serum concentration and psoriasis severity. Elevated resistin levels were associated with higher PASI and BSA scores. Conclusions: Psoriasis is an inflammatory disease that is potentially linked to metabolic disorders. Resistin may serve as a biomarker for psoriasis severity; however, this relationship requires further research.<\/jats:p>","DOI":"10.3390\/jcm14051689","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T05:52:16Z","timestamp":1740981136000},"page":"1689","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammation-Related Markers in Pediatric Psoriasis: Resistin as a Potential Marker of Psoriasis Severity"],"prefix":"10.3390","volume":"14","author":[{"given":"Magdalena","family":"Szczegielniak","sequence":"first","affiliation":[{"name":"Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Lesiak","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5573-1754","authenticated-orcid":false,"given":"Adam","family":"Reich","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical College of Rzeszow University, 35-055 Rzeszow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Opali\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical College of Rzeszow University, 35-055 Rzeszow, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Zakrzewski","sequence":"additional","affiliation":[{"name":"Zakrzewscy Clinic of Aesthetic Medicine and Dermatology, 40-246 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Arasiewicz","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Vascular Anomalies, John Paul II Centre of Pediatrics, 41-200 Sosnowiec, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Grabowski","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Nolberczak","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Narbutt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Pediatric Dermatology and Oncology, Medical University of Lodz, 90-419 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/bjd.14507","article-title":"Epidemiology of childhood psoriasis: A scoping review","volume":"174","author":"Thomas","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40272-015-0137-1","article-title":"Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities","volume":"17","author":"Bronckers","year":"2015","journal-title":"Paediatr. Drugs"},{"key":"ref_3","first-page":"363","article-title":"Childhood psoriasis","volume":"104","author":"Pietrzak","year":"2017","journal-title":"Dermatol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00431-020-03924-w","article-title":"Metabolic syndrome and insulin resistance in pre-pubertal children with psoriasis","volume":"180","author":"Caroppo","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors","volume":"69","author":"Miller","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjd.16239","article-title":"Nonalcoholic fatty liver disease in patients with psoriasis: A consequence of systemic inflammatory burden?","volume":"179","author":"Prussick","year":"2018","journal-title":"Br. J. Dermatol."},{"doi-asserted-by":"crossref","unstructured":"Sitdikova, G., and Hermann, A. (2023). Homocysteina: Biochemia, biologia molekularna i rola w chorobie 2021. Biomoleku\u0142y, 13.","key":"ref_8","DOI":"10.3390\/biom13071111"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1248\/yakushi.127.1579","article-title":"Metabolizm homocysteiny","volume":"127","author":"Hashimoto","year":"2007","journal-title":"Yakugaku Zasshi"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1741S","DOI":"10.1093\/jn\/136.6.1741S","article-title":"Patofizjologiczne konsekwencje nadmiaru homocysteiny","volume":"136","author":"Jakubowski","year":"2006","journal-title":"J. Nutr."},{"doi-asserted-by":"crossref","unstructured":"Lin, X., Meng, X., and Song, Z. (2019). Homocysteina i \u0142uszczyca. Biosci. Rep., 39.","key":"ref_11","DOI":"10.1042\/BSR20190867"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12098-014-1644-8","article-title":"Childhood obesity, metabolic syndrome and Pentraxin-3","volume":"82","author":"Menon","year":"2015","journal-title":"Indian J. Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2133.2008.08655.x","article-title":"Obesity in psoriasis: Leptin and resistin as mediators of cutaneous inflammation","volume":"159","author":"Johnston","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1097\/01.ASN.0000141966.69934.21","article-title":"The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity","volume":"15","author":"Wisse","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12944-021-01510-z","article-title":"Adiponectin in psoriasis and its comorbidities: A review","volume":"20","author":"Ruiyang","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2147\/DMSO.S321311","article-title":"Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication","volume":"14","author":"Dessie","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"doi-asserted-by":"crossref","unstructured":"Karampinis, E., Goudouras, G., Ntavari, N., Bogdanos, D.P., Roussaki-Schulze, A.V., and Zafiriou, E. (2023). Serum vitamin D levels can be predictive of psoriasis flares up after COVID-19 vaccination: A retrospective case control study. Front. Med., 10.","key":"ref_17","DOI":"10.3389\/fmed.2023.1203426"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/jdv.13023","article-title":"Poziomy homocysteiny w osoczu u pacjent\u00f3w z \u0142uszczyc\u0105: Nasze do\u015bwiadczenia i przegl\u0105d pi\u015bmiennictwa","volume":"29","author":"Giannoni","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.5021\/ad.2019.31.4.378","article-title":"Zwi\u0105zek mi\u0119dzy poziomem homocysteiny a \u0142uszczyc\u0105: Metaanaliza","volume":"31","author":"Kim","year":"2019","journal-title":"Ann. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1684\/ejd.2012.1714","article-title":"Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis","volume":"22","author":"Ruiz","year":"2012","journal-title":"Eur. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102163","DOI":"10.1016\/j.arr.2023.102163","article-title":"Pentraxin 3: A promising therapeutic target for cardiovascular diseases","volume":"93","author":"Ye","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/08916934.2011.611549","article-title":"Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications","volume":"45","author":"Hrycek","year":"2012","journal-title":"Autoimmunity"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12043","article-title":"The long pentraxin PTX3: A paradigm for humoral pattern recognition molecules","volume":"1285","author":"Mantovani","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-007-9126-7","article-title":"Pentraksyny w odporno\u015bci wrodzonej: Od bia\u0142ka C-reaktywnego do d\u0142ugiej pentraksyny PTX3","volume":"28","author":"Mantovani","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"ref_25","first-page":"3453","article-title":"The levels of serum pentraxin3, CRP, fetuin-A, and insulin in patients with psoriasis","volume":"18","author":"Uysal","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_26","first-page":"415","article-title":"Long pentraxin 3: A marker of inflammation in untreated psoriatic patients","volume":"18","author":"Bevelacqua","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.2007.08068.x","article-title":"Obesity in psoriasis: The metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review","volume":"157","author":"Sterry","year":"2007","journal-title":"Br. J. Dermatol."},{"doi-asserted-by":"crossref","unstructured":"Kie\u0142bowski, K., Bakinowska, E., Ostrowski, P., Pala, B., Gromowska, E., Gurazda, K., Dec, P., Modrzejewski, A., and Pawlik, A. (2023). The Role of Adipokines in the Pathogenesis of Psoriasis. Int. J. Mol. Sci., 24.","key":"ref_28","DOI":"10.3390\/ijms24076390"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"25569","DOI":"10.1074\/jbc.M109.019786","article-title":"Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10","volume":"284","author":"Folco","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/24755303231199995","article-title":"Serum Adiponectin Levels as an Independent Marker of Severity of Psoriasis: A Cross-Sectional Analysis","volume":"8","author":"Kaushik","year":"2023","journal-title":"J. Psoriasis Psoriatic Arthritis"},{"key":"ref_31","first-page":"13","article-title":"Serum Visfatin, Adiponectin, and Tumor Necrosis Factor Alpha (TNF-\u03b1) Levels in Patients with Psoriasis and their Correlation with Disease Severity","volume":"24","author":"Sereflican","year":"2016","journal-title":"Acta Dermatovenerol. Croat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.18632\/oncotarget.22260","article-title":"Serum levels of adipokines and cytokines in psoriasis patients: A systematic review and meta-analysis","volume":"9","author":"Bai","year":"2017","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12944-015-0039-9","article-title":"Increased serum resistin levels correlate with psoriasis: A meta-analysis","volume":"14","author":"Huang","year":"2015","journal-title":"Lipids Health Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e290721195114","DOI":"10.2174\/1573403X17666210729101120","article-title":"Resistin and Cardiovascular Disease: A Review of the Current Literature Regarding Clinical and Pathological Relationships","volume":"18","author":"Askin","year":"2022","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1476-5381.2011.01369.x","article-title":"Resistin: Functional roles and therapeutic considerations for cardiovascular disease","volume":"165","author":"Jamaluddin","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5380792","DOI":"10.1155\/2016\/5380792","article-title":"Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients","volume":"2016","author":"Vachatova","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jaad.2014.06.006","article-title":"Increased serum leptin and resistin levels and increased carotid intima-media wall thickness in patients with psoriasis: Is psoriasis associated with atherosclerosis?","volume":"71","author":"Robati","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1468-3083.2010.03647.x","article-title":"Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy","volume":"24","author":"Coimbra","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/jdv.12451","article-title":"Effect of treatment with methotrexate and coal tar on adipokine levels and indices of insulin resistance and sensitivity in patients with psoriasis vulgaris","volume":"29","author":"Rajappa","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_40","first-page":"273","article-title":"Effects of treatment for psoriasis on circulating levels of leptin, adiponectin and resistin: A systematic review and meta-analysis","volume":"179","author":"Kyriakou","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jaad.2024.05.034","article-title":"JAAD Game Changers: \u201cIncreased serum leptin and resistin levels and increased carotid intima-media wall thickness in patients with psoriasis: Is psoriasis associated with atherosclerosis\u201d?","volume":"91","author":"Brodell","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"doi-asserted-by":"crossref","unstructured":"Su, X., Cheng, Y., and Chang, D. (2021). The Important Role of Leptin in Modulating the Risk of Dermatological Diseases. Front. Immunol., 11.","key":"ref_42","DOI":"10.3389\/fimmu.2020.593564"},{"doi-asserted-by":"crossref","unstructured":"Toussirot, E., Aubin, F., and Dumoulin, G. (2014). Relationships between Adipose Tissue and Psoriasis, with or without Arthritis. Front. Immunol., 5.","key":"ref_43","DOI":"10.3389\/fimmu.2014.00368"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/ced.12171","article-title":"Leptin levels in patients with psoriasis: A meta-analysis","volume":"38","author":"Zhu","year":"2013","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archderm.144.12.1571","article-title":"Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome","volume":"144","author":"Chen","year":"2008","journal-title":"Arch. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1468-3083.2011.03982.x","article-title":"The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis","volume":"25","author":"Kaur","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/5\/1689\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:46:02Z","timestamp":1760028362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/5\/1689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["jcm14051689"],"URL":"https:\/\/doi.org\/10.3390\/jcm14051689","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}